Stem Cells Seem Safe in Treating Eye Disease
October 16, 2014
(MIT Technology Review) – But today, a Massachusetts biotech firm reported results from the largest, and longest, human test of a treatment based on embryonic stem cells, saying it appears safe and may have partly restored vision to patients going blind from degenerative diseases. Results of the three-year study were described today in the Lancet by Advanced Cell Technology and collaborating eye specialists at the Jules Stein Eye Institute in Los Angeles, who transplanted lab-grown cells into the eyes of nine people with macular degeneration and nine with Stargardt’s macular dystrophy.